Skip to main content

Table 5 Univariate logistic regression analysis of factors affecting tumor response rate (ZIO 50%)

From: Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

   Odds ratio (95% CI) P
After EC + DOC     
  Age (years)    
     <51 1.000   
     51≤ 0.800 (0.192-3.333) 0.7592
  Cancer stage    
     II 1.000   
     III, IV 5.750 (1.028-32.174) 0.0465
  Tumor stage    
     T2 1.000   
     T3 7.833 (1.279-47.964) 0.0260
  Nodal status    
     N- 1.000   
     N+ 6.286 (0.730-54.110) 0.0942
  Subtype    
     Luminal A, B 1.000   
     HER2, Basal-like 3.958 (0.913-17.154) 0.0659
  DDR score    
     0, 1, 2 1.000   
     3, 4 9.423 (1.729-51.359) 0.0095
  1. CI, confidence interval; DDR, DNA Damage Response; DOC, docetaxel; EC, epirubicin plus cyclophosphamide; HER, human epidermal growth factor receptor.